VETO Share Price Performance
€0
-73.60 (-100.00%)
Price €0
Share Pricen/a
Vetoquinol SA Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 14 Fair Values set on narratives written by author
VETO Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Vetoquinol SA Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Sep 11, 2026
- 4.94
- 58.58%
- 10.91%
- 0.3%
About VETO
- Founded
- 1933
- Employees
- 2454
- CEO
- WebsiteView website
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
